MwanzoSTIM • NASDAQ
add
Neuronetics Inc
Bei iliyotangulia
$ 1.32
Bei za siku
$ 1.28 - $ 1.40
Bei za mwaka
$ 1.00 - $ 5.91
Thamani ya kampuni katika soko
91.77M USD
Wastani wa hisa zilizouzwa
2.04M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
CityNews Halifax
saa 15 zilizopita
S&P/TSX composite up more than 100 points, U.S. stock markets mixed
0.36%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 37.30M | 101.28% |
Matumizi ya uendeshaji wa biashara | 24.43M | 12.43% |
Mapato halisi | -9.04M | 32.20% |
Kiwango cha faida halisi | -24.25 | 66.32% |
Mapato kwa kila hisa | -0.13 | 70.45% |
EBITDA | -6.44M | 10.82% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 27.97M | 34.04% |
Jumla ya mali | 145.46M | 96.26% |
Jumla ya dhima | 114.10M | 76.26% |
Jumla ya hisa | 31.36M | — |
hisa zilizosalia | 68.49M | — |
Uwiano wa bei na thamani | 3.30 | — |
Faida inayotokana na mali | -13.07% | — |
Faida inayotokana mtaji | -15.62% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -9.04M | 32.20% |
Pesa kutokana na shughuli | elfu -785.00 | 85.51% |
Pesa kutokana na uwekezaji | elfu -114.00 | -914.29% |
Pesa kutokana na ufadhili | 17.90M | 209.34% |
Mabadiliko halisi ya pesa taslimu | 17.00M | 178.08% |
Mtiririko huru wa pesa | 5.35M | 287.96% |
Kuhusu
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
Ilianzishwa
2003
Makao Makuu
Wafanyakazi
716
